[Cytokeratins--survey of incidence in normal and diseased skin. II. Cytokeratin expression in diseased skin].
The distribution patterns of cytokeratins demonstrated by different authors in benign and malignant tumours of the skin are presented and the resulting possibilities for histological differentiation are discussed. The monoclonal antibody A53-B/A2 made in GDR may be useful in the diagnosis of Merkel cell tumours or of the extramammary Morbus Paget. -For different dermatoses, especially some disease with abnormal types of keratinization, the expressed polypeptides are described.
Heidenbluth
I
I
Klinik für Hautkrankheiten, Medizinischen Akademie, Carl Gustav Carus, Dresden, DDR.
Conrad
K
K
D014408:Biomarkers, Tumor / Q000032:analysis*; D003937:Diagnosis, Differential; D006801:Humans; D007633:Keratins / Q000032:analysis*; D010455:Peptides / Q000032:analysis; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000175:diagnosis*; D012878:Skin Neoplasms / Q000175:diagnosis*
D014408:Biomarkers, Tumor; D010455:Peptides; D007633:Keratins
Zytokeratine--Uberblick über das Vorkommen in normaler und kranker Haut. II. Zytokeratinexpression in erkrankter Haut.